Brendan M. McGuire

Brendan McGuire practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Brendan McGuire's NPI, 1336179688, was assigned on July 3, 2006. Brendan McGuire graduated from University of Pittsburgh School of Medicine in 1996. Brendan McGuire holds Alabama license 19964.

Brendan McGuire's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Brendan McGuire's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Brendan McGuire is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Brendan McGuire to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brendan McGuire practices, 5 sites in all. Vendor and product names are available with a free account.

Hepatology is Brendan McGuire's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Brendan McGuire is licensed in Alabama.

CMS data shows 700 Medicare services from Brendan McGuire across 12 procedure codes in 2024, for 296 Medicare patients. Medicare paid $41,045 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 296 Medicare patients who saw Brendan McGuire in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brendan McGuire's median patient age at 62, with 47% women.

In 2024, Brendan McGuire wrote 1,916 Medicare Part D claims for 395 patients. 83% of them were for generic drugs. CMS names the drug for 1,600 of them, across 35 drugs with 11 or more claims each, at $818,005 in total drug cost. In 2023, CMS named 1,716 claims across 36 drugs.

Brendan McGuire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 80 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Brendan McGuire, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 46 papers to Brendan McGuire, published from 2009 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Liver Transplantation, Liver Failure, Acute and Liver Cirrhosis. Brendan McGuire has published most often in Hepatology. Brendan McGuire's most frequent co-authors are Richard T. Stravitz, MD, William Martens Lee, MD and Bilal Hameed, MD.

Dmand AI links Brendan McGuire to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Liver Failure, alpha 1-Antitrypsin Deficiency and Hepatic Encephalopathy.

CMS Open Payments shows 183 general payments to Brendan McGuire from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Mallinckrodt Hospital Products Inc. paid the most, $8,125. It also lists 1 research payment totaling $42 in 2017.

Brendan McGuire graduated from University of Pittsburgh School of Medicine in 1996.